CCL2 and Miyoshi myopathy: Trabectedin, a DNA-binding sea squirt-derived molecule, was investigated in human leukemic and MM cells, in which it could kill monocytes and macrophages and exert an antiangiogenic role through the inhibition of VEGF and CCL2 production [130].